LYFE Capital
Menlo Park, Californialyfecapital.com
Overview
LYFE Capital is a global healthcare investment platform that focuses on venture opportunities. It invests in the healthcare industry in the US, Singapore, South Korea, Japan and China . With 5 global offices in Asia and the U.S., the firm focuses on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, allowing them to grow significant and resilient revenues from global mature markets .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Starna Therapeutics | May 2026 | Series B Extension | Co-investor |
| Koru Pharma Co., Ltd. | May 2026 | Private Equity | Lead |
| Aspen Neuroscience | Nov 2025 | Series C | Co-investor |
| Starna Therapeutics | Oct 2025 | Series B | Lead |
| Neurona Therapeutics | Apr 2025 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
